Gan & Lee Pharmaceuticals Co., Ltd.SSE: 603087

Indicative Announcement on Changes in Shareholder's Equity

Jul 30, 2025 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 30, 2025

On 6ix: 6ix.com/news/indicative-announcement-on-changes-in-shareholders-equity-37

Indicative Announcement on Changes in Shareholder's Equity

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Gan & Lee Pharmaceuticals Co., Ltd. on 6ix

Earlier from Gan & Lee Pharmaceuticals

Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public OfferingJul 22, 2025
Announcement on Progress in Using Idle Raised Funds for Cash ManagementJul 15, 2025
Announcement on Redemption at Maturity of Idle Raised Funds Used for Cash ManagementJul 11, 2025
Announcement on Expected Increase in Semi-annual Performance for 2025Jul 10, 2025
Announcement on Shareholding Reduction Plan of Shareholders, Directors and Senior Management MembersJul 5, 2025

Later from Gan & Lee Pharmaceuticals

Announcement on Progress in Repurchasing Shares through Call AuctionAug 2, 2025
Announcement on Resolutions of the 3rd Meeting of the 5th Board of SupervisorsAug 8, 2025
Announcement on Completion of Administration of the First Subject in Phase II Clinical Trial of GZR102 InjectionAug 9, 2025
Announcement on the Result of Shareholding Reduction by Shareholder and DirectorAug 16, 2025
Announcement on Results of Shareholding Reduction by Senior Management MembersAug 21, 2025

All Gan & Lee Pharmaceuticals news releases

Follow Gan & Lee Pharmaceuticals into a list and get an email when it puts out news.

Follow Gan & Lee Pharmaceuticals